methylprednisolone


Also found in: Medical, Acronyms, Wikipedia.
Related to methylprednisolone: Methylprednisolone sodium succinate

meth·yl·pred·nis·o·lone

 (mĕth′əl-prĕd-nĭs′ə-lōn′)
n.
A glucocorticoid used therapeutically primarily as an anti-inflammatory agent.
Translations

methylprednisolone

n metilprednisolona
References in periodicals archive ?
has issued a voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g, the company said.
An excellent response to methylprednisolone suggested HIDAC-induced immune-mediated neuropathy occurred due to either by nerve damage with resultant exposure or modification of peripheral nerve antigen or by an effect on reconstituting immune cells,[3] and same observation was obtained in this case report also.
4 g/kg daily for five days) and 1 g of methylprednisolone daily for five days, followed by tapering doses of prednisone over four weeks.
An earlier animal study also demonstrated the beneficial effect of methylprednisolone on laser-induced retinal lesions.
In group 3 (n=8), the thioacetami de+methylprednisolone group, treatment with methylprednisolone (30 mg/kg intraperitoneal) was commenced 48 h before the first dose of thioacetamide.
With injection of methylprednisolone acetate with the use of two needle technique (Fig.
9362) published this week reported an international trial of oral methylprednisolone involving 262 patients (including Australians) was stopped early due to safety concerns.
As Edward Benzel and his colleagues said in 2000, "The reporting of the results of National Acute Spinal Cord Injury Studies II and III has been incomplete, leaving clinicians in the spinal cord injury community to use or avoid using methylprednisolone in acute SCI on the basis of FAITH rather than a publicly developed scientific consensus".
2) This trial had 3 arms with 37 patients in each: 80-mg methylprednisolone injection, 40-mg methylprednisolone injection, or placebo injection.
The serum IL-33 concentrations in treated MS patients with methylprednisolone or both of IFN-[beta] plus methylprednisolone were significantly higher than the control group (p< 0.
Women experiencing particularly unmanageable nausea and vomiting or HG may find methylprednisolone, 48 mg taken daily orally or intravenously for 3 days, effective in reducing symptoms.